Envestnet Portfolio Solutions Inc. Increases Stake in Mettler-Toledo International Inc. (NYSE:MTD)

Envestnet Portfolio Solutions Inc. increased its holdings in Mettler-Toledo International Inc. (NYSE:MTD) by 5.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 513 shares of the medical instruments supplier’s stock after acquiring an additional 28 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in Mettler-Toledo International were worth $628,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Farther Finance Advisors LLC lifted its position in shares of Mettler-Toledo International by 14.3% in the 4th quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier’s stock worth $78,000 after purchasing an additional 8 shares during the period. Townsquare Capital LLC raised its stake in Mettler-Toledo International by 2.0% in the third quarter. Townsquare Capital LLC now owns 462 shares of the medical instruments supplier’s stock worth $693,000 after buying an additional 9 shares in the last quarter. M3 Advisory Group LLC lifted its holdings in Mettler-Toledo International by 5.8% during the fourth quarter. M3 Advisory Group LLC now owns 165 shares of the medical instruments supplier’s stock worth $202,000 after buying an additional 9 shares during the period. Apollon Wealth Management LLC boosted its position in Mettler-Toledo International by 2.5% during the 4th quarter. Apollon Wealth Management LLC now owns 368 shares of the medical instruments supplier’s stock valued at $451,000 after acquiring an additional 9 shares in the last quarter. Finally, Steward Partners Investment Advisory LLC increased its holdings in shares of Mettler-Toledo International by 3.0% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 306 shares of the medical instruments supplier’s stock valued at $374,000 after acquiring an additional 9 shares during the period. 95.07% of the stock is currently owned by institutional investors.

Mettler-Toledo International Trading Up 1.0 %

NYSE:MTD opened at $1,211.71 on Tuesday. The company has a market capitalization of $25.25 billion, a P/E ratio of 29.90, a PEG ratio of 3.30 and a beta of 1.15. Mettler-Toledo International Inc. has a 12 month low of $1,142.91 and a 12 month high of $1,546.93. The firm has a fifty day simple moving average of $1,291.57 and a 200-day simple moving average of $1,308.45.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, beating the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. Equities analysts forecast that Mettler-Toledo International Inc. will post 42.71 EPS for the current year.

Analysts Set New Price Targets

MTD has been the topic of a number of recent research reports. Citigroup dropped their price objective on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 4th. Robert W. Baird lifted their price objective on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Wolfe Research assumed coverage on shares of Mettler-Toledo International in a research report on Friday, December 13th. They set a “peer perform” rating for the company. Wells Fargo & Company lifted their price target on shares of Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the stock an “equal weight” rating in a report on Monday, February 10th. Finally, Evercore ISI increased their price objective on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a report on Monday, February 10th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $1,380.50.

Insiders Place Their Bets

In other Mettler-Toledo International news, insider Christian Magloth sold 790 shares of the stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the sale, the insider now directly owns 734 shares of the company’s stock, valued at approximately $964,248.46. This trade represents a 51.84 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Gerry Keller sold 600 shares of the business’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the transaction, the insider now directly owns 6 shares of the company’s stock, valued at approximately $8,108.04. This trade represents a 99.01 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by insiders.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.